• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估肿瘤内芳香酶活性的芳香酶单克隆抗体的表位特征。

Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity.

机构信息

Division of Tumor Cell Biology, Beckman Research Institute of the City of Hope, Duarte, California, United States of America.

出版信息

PLoS One. 2009 Nov 30;4(11):e8050. doi: 10.1371/journal.pone.0008050.

DOI:10.1371/journal.pone.0008050
PMID:19956630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2778552/
Abstract

Immunohistochemistry is one of the most suitable methods for the detection of intratumoral aromatase in order to identify patients who may respond to aromatase inhibitor therapy in hormone-dependent breast cancer. Previous studies showed statistically significant correlation between results of immnuohistochemistry and biochemical analysis in carcinoma components stained by aromatase monoclonal antibody 677. In this study, determination of the antigenic peptides recognized by aromatase antibodies through epitope mapping, combined with the new knowledge on aromatase-reductase interaction, provide insights for understanding various immunostaining patterns using different aromatase antibodies. Our studies on aromatase-reductase interaction also provided critical information on how aromatase and reductase interact with each other on the endoplasmic reticulum membrane, and identified key residues, including K108 of aromatase, that are involved in the interaction with reductase. Through epitope mapping and taking into consideration the interference with aromatase immunohistochemical staining by NADPH-cytochrome P450 reductase, we demonstrated that monoclonal antibody 677 is a suitable antibody for an assessment of intratumoral aromatase activity in breast cancer patients for making clinical management decisions. These results also provide valuable information to identify new aromatase antibodies for immunohistochemical diagnosis of hormone-dependent breast cancer in future.

摘要

免疫组织化学是检测肿瘤内芳香酶的最适宜方法之一,目的是鉴定出激素依赖性乳腺癌中可能对芳香酶抑制剂治疗有反应的患者。先前的研究表明,用芳香酶单克隆抗体 677 染色的癌组织成分的免疫组织化学和生化分析结果之间存在统计学显著相关性。在这项研究中,通过表位作图确定芳香酶抗体识别的抗原肽,结合对芳香酶-还原酶相互作用的新知识,为理解使用不同芳香酶抗体的各种免疫染色模式提供了见解。我们对芳香酶-还原酶相互作用的研究还提供了关于芳香酶和还原酶如何在内质网膜上相互作用的关键信息,并确定了关键残基,包括芳香酶的 K108,这些残基参与与还原酶的相互作用。通过表位作图并考虑 NADPH-细胞色素 P450 还原酶对芳香酶免疫组织化学染色的干扰,我们证明了单克隆抗体 677 是评估乳腺癌患者肿瘤内芳香酶活性以做出临床管理决策的合适抗体。这些结果还为未来识别用于激素依赖性乳腺癌免疫组织化学诊断的新的芳香酶抗体提供了有价值的信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/37aa5411daee/pone.0008050.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/626cf7a4e9c5/pone.0008050.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/bfd8becdfe54/pone.0008050.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/0ab039d3c66b/pone.0008050.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/ff012637e295/pone.0008050.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/ac14082a0f1e/pone.0008050.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/4e93cf960602/pone.0008050.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/37aa5411daee/pone.0008050.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/626cf7a4e9c5/pone.0008050.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/bfd8becdfe54/pone.0008050.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/0ab039d3c66b/pone.0008050.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/ff012637e295/pone.0008050.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/ac14082a0f1e/pone.0008050.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/4e93cf960602/pone.0008050.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d2d/2778552/37aa5411daee/pone.0008050.g007.jpg

相似文献

1
Epitope characterization of an aromatase monoclonal antibody suitable for the assessment of intratumoral aromatase activity.用于评估肿瘤内芳香酶活性的芳香酶单克隆抗体的表位特征。
PLoS One. 2009 Nov 30;4(11):e8050. doi: 10.1371/journal.pone.0008050.
2
Functional characterization of 102-amino acid-deleted form of human aromatase (delta102-aromatase).人芳香化酶102个氨基酸缺失形式(δ102-芳香化酶)的功能特性
Steroids. 1999 Jun;64(6):422-9. doi: 10.1016/s0039-128x(99)00019-7.
3
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer.用于免疫组织化学的新型芳香化酶单克隆抗体的验证——与46例乳腺癌生化活性的相关性
J Steroid Biochem Mol Biol. 2005 May;95(1-5):35-9. doi: 10.1016/j.jsbmb.2005.04.027.
4
Epitope mapping of antibodies by mass spectroscopy: a case study.通过质谱法进行抗体的表位作图:一个案例研究
Methods Mol Biol. 2013;988:291-302. doi: 10.1007/978-1-62703-327-5_18.
5
Immunolocalization of aromatase in human breast disorders using different antibodies.使用不同抗体对人乳腺疾病中芳香化酶进行免疫定位
Breast Cancer Res Treat. 1998;49 Suppl 1:S79-84; discussion S109-19. doi: 10.1023/a:1006009128920.
6
Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies.对人甲状腺过氧化物酶713 - 720区域进行定向诱变,确定713KFPED717残基参与人自身抗体识别的不连续免疫显性区域的B结构域。
J Biol Chem. 2004 Sep 10;279(37):39058-67. doi: 10.1074/jbc.M403897200. Epub 2004 May 18.
7
Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7.鉴定百日咳毒素单克隆抗体 1B7 识别的关键中和表位。
Biochemistry. 2009 Dec 22;48(50):11982-93. doi: 10.1021/bi901532z.
8
Fine epitope mapping of monoclonal antibody 5F1 reveals anticatalytic activity toward the N domain of human angiotensin-converting enzyme.单克隆抗体5F1的精细表位图谱揭示了其对人血管紧张素转换酶N结构域的抗催化活性。
Biochemistry. 2007 Aug 7;46(31):9019-31. doi: 10.1021/bi700489v. Epub 2007 Jul 14.
9
Structure of an activity suppressing Fab fragment to cytochrome P450 aromatase: insights into the antibody-antigen interactions.
Mol Immunol. 1999 May;36(7):423-32. doi: 10.1016/s0161-5890(99)00062-0.
10
Epitope Mapping of Monoclonal Antibody PMab-52 Against Cat Podoplanin.抗猫血小板反应蛋白单克隆抗体PMab-52的表位作图
Monoclon Antib Immunodiagn Immunother. 2018 Apr;37(2):95-99. doi: 10.1089/mab.2017.0067. Epub 2018 Feb 2.

引用本文的文献

1
Influence of cholesterol on kinetic parameters for human aromatase (P450 19A1) in phospholipid nanodiscs.胆固醇对人源芳香化酶(P45019A1)在磷脂纳米盘中的动力学参数的影响。
J Inorg Biochem. 2023 Oct;247:112340. doi: 10.1016/j.jinorgbio.2023.112340. Epub 2023 Jul 24.
2
Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases.一系列病例中犬类乳腺癌与人乳腺癌之间的激素同源性
Vet Sci. 2022 Jul 29;9(8):395. doi: 10.3390/vetsci9080395.
3
Influence of CYP19A1 gene expression levels in women with breast cancer: a systematic review of the literature.

本文引用的文献

1
Molecular characterization of aromatase.芳香化酶的分子特征
Ann N Y Acad Sci. 2009 Feb;1155:112-20. doi: 10.1111/j.1749-6632.2009.03703.x.
2
Structure and function of an NADPH-cytochrome P450 oxidoreductase in an open conformation capable of reducing cytochrome P450.一种处于开放构象、能够还原细胞色素P450的NADPH-细胞色素P450氧化还原酶的结构与功能
J Biol Chem. 2009 Apr 24;284(17):11374-84. doi: 10.1074/jbc.M807868200. Epub 2009 Jan 26.
3
Structural basis for androgen specificity and oestrogen synthesis in human aromatase.
乳腺癌患者 CYP19A1 基因表达水平的影响:文献系统评价。
Clinics (Sao Paulo). 2021 Jun 14;76:e2846. doi: 10.6061/clinics/2021/e2846. eCollection 2021.
4
Molecular and Structural Evolution of Cytochrome P450 Aromatase.细胞色素 P450 芳香化酶的分子和结构进化。
Int J Mol Sci. 2021 Jan 10;22(2):631. doi: 10.3390/ijms22020631.
5
Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.芳香酶乙酰化模式及对组蛋白去乙酰化酶抑制的反应改变。
Mol Cancer Res. 2018 Oct;16(10):1530-1542. doi: 10.1158/1541-7786.MCR-18-0047. Epub 2018 Jun 19.
6
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer.二甲双胍抑制绝经后乳腺癌啮齿动物模型中基质细胞芳香酶的表达和肿瘤进展。
Breast Cancer Res. 2018 Jun 14;20(1):50. doi: 10.1186/s13058-018-0974-2.
7
Molecular simulations of aromatase reveal new insights into the mechanism of ligand binding.分子模拟研究芳香酶揭示了配体结合机制的新见解。
J Chem Inf Model. 2013 Aug 26;53(8):2047-56. doi: 10.1021/ci400225w. Epub 2013 Aug 9.
8
HIF-1α stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma.低氧诱导因子-1α刺激前列腺素E2驱动的乳腺脂肪基质中芳香化酶的表达。
Breast Cancer Res. 2013 Apr 8;15(2):R30. doi: 10.1186/bcr3410.
9
Binding features of steroidal and nonsteroidal inhibitors.甾体和非甾体抑制剂的结合特征。
Steroids. 2011 Jul;76(8):802-6. doi: 10.1016/j.steroids.2011.02.037. Epub 2011 Mar 21.
10
Higher order organization of human placental aromatase.人类胎盘芳香化酶的高级组织结构。
Steroids. 2011 Jul;76(8):753-8. doi: 10.1016/j.steroids.2011.02.030. Epub 2011 Mar 8.
人类芳香化酶中雄激素特异性和雌激素合成的结构基础。
Nature. 2009 Jan 8;457(7226):219-23. doi: 10.1038/nature07614.
4
Integrating statistical pair potentials into protein complex prediction.将统计对偶势整合到蛋白质复合物预测中。
Proteins. 2007 Nov 15;69(3):511-20. doi: 10.1002/prot.21502.
5
Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.芳香化反应及依西美坦介导的人芳香化酶不可逆抑制的分子基础。
Mol Endocrinol. 2007 Feb;21(2):401-14. doi: 10.1210/me.2006-0281. Epub 2006 Nov 9.
6
The validation of new aromatase monoclonal antibodies for immunohistochemistry--a correlation with biochemical activities in 46 cases of breast cancer.用于免疫组织化学的新型芳香化酶单克隆抗体的验证——与46例乳腺癌生化活性的相关性
J Steroid Biochem Mol Biol. 2005 May;95(1-5):35-9. doi: 10.1016/j.jsbmb.2005.04.027.
7
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report.用于免疫组织化学的新型芳香化酶单克隆抗体的验证:进展报告。
J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):239-44. doi: 10.1016/s0960-0760(03)00363-7.
8
Development and validation of a new monoclonal antibody to mammalian aromatase.一种针对哺乳动物芳香化酶的新型单克隆抗体的研发与验证
J Endocrinol. 2002 Jan;172(1):21-30. doi: 10.1677/joe.0.1720021.
9
Structure of a cytochrome P450-redox partner electron-transfer complex.细胞色素P450-氧化还原伴侣电子传递复合物的结构。
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):1863-8. doi: 10.1073/pnas.96.5.1863.
10
Comparison of biochemical aromatase activity with aromatase immunohistochemistry in human breast carcinomas.人乳腺癌中生化芳香化酶活性与芳香化酶免疫组化的比较。
Breast Cancer Res Treat. 1998;49 Suppl 1:S101-7; discussion S109-19. doi: 10.1023/a:1006033813899.